313 related articles for article (PubMed ID: 19254969)
1. Treatment satisfaction of diabetic patients: what are the contributing factors?
Biderman A; Noff E; Harris SB; Friedman N; Levy A
Fam Pract; 2009 Apr; 26(2):102-8. PubMed ID: 19254969
[TBL] [Abstract][Full Text] [Related]
2. Clinical and socio-economic correlates of quality of life and treatment satisfaction in patients with type 2 diabetes.
Nicolucci A; Cucinotta D; Squatrito S; Lapolla A; Musacchio N; Leotta S; Vitali L; Bulotta A; Nicoziani P; Coronel G;
Nutr Metab Cardiovasc Dis; 2009 Jan; 19(1):45-53. PubMed ID: 18450436
[TBL] [Abstract][Full Text] [Related]
3. [Costs of antihyperglycemic drugs and consumables and treatment satisfaction in patients with type 2 diabetes. Results of the health care research study LIVE-DE (long-acting insulin glargine compared with NPH insulin in Germany)].
Hauner H; Kohlmann T; Landgraf W; Holle R; Pirk O; Scholten T
Dtsch Med Wochenschr; 2009 Jun; 134(23):1207-13. PubMed ID: 19472091
[TBL] [Abstract][Full Text] [Related]
4. Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.
Pawaskar MD; Camacho FT; Anderson RT; Cobden D; Joshi AV; Balkrishnan R
Clin Ther; 2007 Jun; 29(6 Pt 1):1294-305. PubMed ID: 18036391
[TBL] [Abstract][Full Text] [Related]
5. Quality of diabetes care in the community: a cross-sectional study in central Israel.
Vinker S; Nakar S; Ram R; Lustman A; Kitai E
Isr Med Assoc J; 2005 Oct; 7(10):643-7. PubMed ID: 16259344
[TBL] [Abstract][Full Text] [Related]
6. Cost sharing, adherence, and health outcomes in patients with diabetes.
Gibson TB; Song X; Alemayehu B; Wang SS; Waddell JL; Bouchard JR; Forma F
Am J Manag Care; 2010 Aug; 16(8):589-600. PubMed ID: 20712392
[TBL] [Abstract][Full Text] [Related]
7. Socio-economic inequalities in the prevalence of Type 2 diabetes, cardiovascular risk factors and chronic diabetic complications in the Basque Country, Spain.
Larrañaga I; Arteagoitia JM; Rodriguez JL; Gonzalez F; Esnaola S; Piniés JA;
Diabet Med; 2005 Aug; 22(8):1047-53. PubMed ID: 16026371
[TBL] [Abstract][Full Text] [Related]
8. The DIAB.&TE.S Project: how patients perceive diabetes and diabetes therapy.
Marra G;
Acta Biomed; 2004 Dec; 75(3):164-70. PubMed ID: 15796090
[TBL] [Abstract][Full Text] [Related]
9. [Patient classification and analysis of risk profiles for type 2 diabetics as the main focus point in practice. Results of the TEMPO study].
Lippmann-Grob B; Bierwirth RA; Kron P; Leinhos B; Funke K; Huptas M; Grüneberg M; Weich KW; Münscher C; Potthoff F
Dtsch Med Wochenschr; 2004 Jan; 129(3):75-81. PubMed ID: 14724780
[TBL] [Abstract][Full Text] [Related]
10. An empirical basis for standardizing adherence measures derived from administrative claims data among diabetic patients.
Karve S; Cleves MA; Helm M; Hudson TJ; West DS; Martin BC
Med Care; 2008 Nov; 46(11):1125-33. PubMed ID: 18953222
[TBL] [Abstract][Full Text] [Related]
11. Quality of life and treatment satisfaction in the context of diabetes self-management education.
Gurková E; Cáp J; Ziaková K
Int J Nurs Pract; 2009 Apr; 15(2):91-8. PubMed ID: 19335526
[TBL] [Abstract][Full Text] [Related]
12. Impact of metformin-induced gastrointestinal symptoms on quality of life and adherence in patients with type 2 diabetes.
Florez H; Luo J; Castillo-Florez S; Mitsi G; Hanna J; Tamariz L; Palacio A; Nagendran S; Hagan M
Postgrad Med; 2010 Mar; 122(2):112-20. PubMed ID: 20203462
[TBL] [Abstract][Full Text] [Related]
13. Measuring the satisfaction of intensive care unit patient families in Morocco: a regression tree analysis.
Damghi N; Khoudri I; Oualili L; Abidi K; Madani N; Zeggwagh AA; Abouqal R
Crit Care Med; 2008 Jul; 36(7):2084-91. PubMed ID: 18552683
[TBL] [Abstract][Full Text] [Related]
14. Psychometric evaluation of the Satisfaction with Oral Anti-Diabetic Agent Scale (SOADAS).
Donatti C; Wild D; Horblyuk R; Beusterien KM; Anderson RT; Arondekar B; Dibenedetti DB
Diabetes Res Clin Pract; 2008 Apr; 80(1):108-13. PubMed ID: 18207601
[TBL] [Abstract][Full Text] [Related]
15. Identifying factors that affect patients' willingness to pay for inhaled insulin.
Pinto SL; Holiday-Goodman M; Black CD; Lesch D
Res Social Adm Pharm; 2009 Sep; 5(3):253-61. PubMed ID: 19733826
[TBL] [Abstract][Full Text] [Related]
16. Type 2 diabetes in primary care in belgium: need for structured shared care.
Goderis G; Borgermans L; Heyrman J; Broeke CV; Grol R; Boland B; Mathieu C
Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):367-72. PubMed ID: 19358093
[TBL] [Abstract][Full Text] [Related]
17. Treatment preferences and medication adherence of people with Type 2 diabetes using oral glucose-lowering agents.
Hauber AB; Mohamed AF; Johnson FR; Falvey H
Diabet Med; 2009 Apr; 26(4):416-24. PubMed ID: 19388973
[TBL] [Abstract][Full Text] [Related]
18. Patient-reported tolerability issues with oral antidiabetic agents: Associations with adherence; treatment satisfaction and health-related quality of life.
Pollack MF; Purayidathil FW; Bolge SC; Williams SA
Diabetes Res Clin Pract; 2010 Feb; 87(2):204-10. PubMed ID: 20036433
[TBL] [Abstract][Full Text] [Related]
19. Patient-reported perceptions of side effects of antihyperglycemic medication and adherence to medication regimens in persons with diabetes mellitus.
Chao J; Nau DP; Aikens JE
Clin Ther; 2007 Jan; 29(1):177-80. PubMed ID: 17379058
[TBL] [Abstract][Full Text] [Related]
20. Clinical and economic outcomes associated with National Kidney Foundation guideline-concordant oral antidiabetic drug treatment among type 2 diabetes patients with chronic kidney disease.
Chen SY; Siu K; Kovacs B; Stokes M; Rao P; Sander S; Boulanger L
Curr Med Res Opin; 2012 Apr; 28(4):493-501. PubMed ID: 22364567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
